ASPIRE Collaborative
Meeting
July 17th 2026
THANK YOU!
THANK YOU!
Upcoming Events
MPOG Annual Retreat
October 16, 2026
San Diego and Virtual
•45 sites across the state!
•No new sites anticipated
for 2027
Automated Data Pilot Update
Site 1
EHR
Site 2
EHR
Site 3
EHR
How can we help our abstractors, ACQRs, SQCRs, Quality Champions
understand sepsis management and outcomes better?
Computation
Storage
MSQC
HMS
ASPIRE
Sepsis
ICU
A tale of working with hospital IT….
•HMS, ASPIRE, and MSQC are collaborating on a pilot project that expands the time
boundaries of our automated extract from the immediate perioperative period to the entire
acute care encounter
•Investigating sepsis management and outcomes
•Use ASPIRE processes for computed phenotype and measure build development
•4 hospitals –UM Ann Arbor, Sparrow, West, and Trinity + Technology partner
•Status: extracted UMAA data and currently exploring
•Working with hospital IT at West, Sparrow, and Trinity
•Still committed to completing this pilot and understanding the opportunities and challenges
to scaling this methodology
Pay-for-Performance (P4P) Scorecard
2027
Participation Measures
Cohorts 1-8
Measure # Weight Measure Description Points
Collaborative Meeting Participation: ASPIRE Quality Champion
and Anesthesiology Clinical Quality Reviewer (ACQR)
combined attendance at meetings. Three total meetings with
six opportunities for attendance.
6/6 Meetings 10
5/6 Meetings 5
4 or Less Meetings 0
Attend ASPIRE Quality Committee e-meetings: ASPIRE Quality
Champion or ACQR attendance across six meetings.
5 - 6/6 Meetings 5
4 or Less Meetings 0
ACQR/ASPIRE Quality Champion perform data validation, case
validation and submit data by the 3rd Wednesday of each
month for January - November and by the 2nd Wednesday of
the month for December. Data must be of high quality upon
submission with >90% of all high priority and required
diagnostics marked as 'Data Accurately Represented.'
10 - 12/12 Months 5
9 or Less Months 0
Site Based Quality Meetings: Sites to hold an onsite in-person
or virtual meeting following the three ASPIRE Collaborative
meetings to discuss the data and plans for quality
improvement at their site.
3 Meetings 5
1 - 2 Meetings 0
35%
45%
110%
2027 Anesthesiology Performance Improvement and Reporting Exchange (ASPIRE) Collaborative Quality
Initiative Performance Index Scorecard
Cohort 1 - 8
Measurement Period: 10/01/2026 - 9/30/2027
25%
A maximum of 25 points can be earned
from participation measures.
For more information, visit the ASPIRE 2027 P4P website.
SMOK-02 : Increase percentage of adult patients who are
documented as current tobacco smokers and also receive an
approved smoking cessation intervention from an anesthesia
provider
Performance score >=90% or absolute performance improves
by >=20 percentage points
25
Performance score >=85% or absolute performance improves
by >=15 percentage points
15
Performance score >=80% or absolute performance improves
by >=10 percentage points
10
Performance score <80% and improvement is less than 10
percentage points
0
GLU-11 : Increase percentage of adult patients with
perioperative blood glucose >180 mg/dL with documentation
of treatment within 90 minutes
Performance score >=75% or absolute performance improves
by >=20 percentage points
25
Performance score >=70% or absolute performance improves
by >=15 percentage points
15
Performance score >=65% or absolute performance improves
by >=10 percentage points
10
Performance score <65% and improvement is less than 10
percentage points
0
SUS-04: Increase percentage of cases with mean fresh gas flow
(FGF) less than or equal to 2L/min for the administration of
inhaled anesthetics and/or nitrous oxide during the
maintenance phase of anesthesia
Performance score >=80% 25
Performance score >=75% 15
Performance score >=70% 10
Performance score <70% 0
TOC-01: Increase percentage of patients with documentation
of intraoperative handoff for permanent transfers of care
between in-room anesthesia providers
Performance score >=85% or absolute performance improves
by >=20 percentage points
25
Performance score >=80% or absolute performance improves
by >=15 percentage points
15
Performance score >=75% or absolute performance improves
by >=10 percentage points
10
Performance score <75% and improvement is less than 10
percentage points
0
525%
Of the three measures below, the two measures with the highest point total will be counted toward the final
score.
725%
625%
825%
Performance Measures
Cohorts 1-8
Core Performance Measure
SMOK-02 target: ≥90% earns
full points.
Additional Performance
Measures
Three additional measures will be
assessed. The highest point total
among the three will count toward
the final score.
GLU-11 | SUS-04 | TOC-01
Participation Measures
Cohort 9*
A maximum of 70 points can be earned from
participation measures.
*This P4P Scorecard only applies for
MyMichigan Saginaw and Tawas.
Measure # Weight Measure Description Points
6 / 6 Meetings 20
5 / 6 Meetings 10
<=4 Meetings 0
5 - 6 / 6 Meetings 10
4 Meetings 5
<=3 Meetings 0
11 / 12 Months 20
10 / 12 Months 15
9 / 12 Months 10
<9 Months 0
ASPIRE Quality Champion and ACQR monthly meetings
12 / 12 Months 10
11 / 12 Months 5
<=10 / 12 Months 0
3 Meetings 10
2 Meetings 5
1 Meeting 0
2027 Anesthesiology Quality Improvement and Reporting Exchange (ASPIRE)
Collaborative Quality Initiative Performance Index Scorecard
Cohort 9
Measurement Period: 10/01/2026 - 9/30/2027
210%
410%
20%
120%
3
510%
Performance Measures
Cohort 9*
Core Performance Measures
NMB-01 target: ≥90%
SUS-04 target: >=80%
…to earn full points for both
measures.
NMB 01: Increase percentage of cases with a documented Train
of Four (TOF) after last dose of non-depolarizing neuromuscular
blocker
Performance score >= 90% 15
Performance score >= 85% 10
Performance score >= 80% 5
Performance score < 80% 0
SUS-04: Increase percentage of cases with mean fresh gas flow
(FGF) less than or equal to 2L/min for the administration of
inhaled anesthetics and/or nitrous oxide during the
maintenance phase of anesthesia
Performance score >=80% 15
Performance score >=75% 10
Performance score >=70% 5
Performance score <70% 0
715%
615%
*This P4P Scorecard only applies for MyMichigan Saginaw and Tawas.
For more information, visit the ASPIRE 2027 P4P website.
2028 Value Based Reimbursement
Measurement Period
10/1/26 –9/30/2027
VBR Program Updates
•VBR performance based on hospital-level performance (what you see on the
dashboard) rather than only aggregating performance from eligible attending
anesthesiologists
•These updates will be applied for this year (2027 VBR) and next year (2028
VBR)
•This information was disseminated to Quality Champions, ACQRs, and P4P
administrators via email in May.
Unsure about Provider Eligibility?
•Check with your quality department or practice manager as they may be able to confirm
contract status.
•Individual providers can also call 1-800-822-2761, to check individual status.
•For further details on BCBSM eligibility, please reach out to CQIprograms@bcbsm.com
or visit Enrollment | Providers | BCBSM
New Scoring Methodology for 2028 VBR
•VBR/P4P measurement periods align: October 1, 2026 –September 30, 2027
•VBR eligibility will now be calculated using a Scorecard Index (similar to P4P):
Measures, Points, and VBR Percentage Eligibility Criteria
VBR Eligibility Scale for CQIs offering up to 107%
(Includes tobacco cessation measure.)
Points
Threshold
Points Threshold to Meet 102% VBR eligibility
>= 40-51
Points Threshold to Meet 103% VBR eligibility
>= 52-63
Points Threshold to Meet 104% VBR Eligibility
>= 64-75
Points Threshold to Meet 105% VBR eligibility
>= 76-87
Points Threshold to Meet 107% VBR eligibility
>= 88-100
New Measures
•GLU-11 Target >=75%
•SUS-02 Target >=75%
•SUS-04 Target >=80%
•TEMP-03 Target <=4.5%
•TOC-01 Target >=85%
•SMOK-02 Target >=90%
*New scoring methodology allows for partial credit for
each measure and total points determine %VBR earned
(102-107%)
Measure # Weight Measure Description Points
Measure: GLU-11
Increase percentage of adult patients with perioperative blood glucose >180
mg/dL with documentation of treatment within 90 minutes
Aggregation level: Hospital
Performance score >=75%
20
Performance score >=70%
10
Performance score >=65%
5
Performance score <65%
0
Measure: SUS-02
Increase percentage of cases where carbon dioxide equivalents (CO2
equivalents) normalized by hour for cases receiving inhalational anesthetic
agents is less than CO2 equivalents of 2% sevoflurane at 2L FGF = 2.83 kg
CO2/hr or the Total CO2 equivalents is less than 2.83 kg CO2 for the
maintenance period of anesthesia.
Aggregation level: Hospital
Performance score >=75%
15
Performance score >=70%
10
Performance score >=65%
5
Performance score <65%
0
Measure: SUS-04
Increase percentage of cases with mean fresh gas flow (FGF) less than or
equal to 2L/min for the administration of inhaled anesthetics and/or nitrous
oxide during the maintenance period of anesthesia.
Aggregation level: Hospital
Performance score >=80%
15
Performance score >=75%
10
Performance score >=70%
5
Performance score <70%
0
Measure: TEMP-03 (Outcome measure)
Decrease percentage of patients requiring general or neuraxial anesthesia for
whom a body temperature >=36 degrees Celsius (or 96.8 degrees Fahrenheit)
was not recorded within 30 minutes before to 15 minutes after anesthesia end
time.
Aggregation level: Hospital
Performance score <=4.5%
15
Performance score <=5.5%
10
Performance score <=6.5%
5
Performance score >6.5%
0
Measure: TOC-01
Increase percentage of patients with documentation of intraoperative handoff
for permanent transfers of care between in-room anesthesia providers.
Aggregation level: Hospital
Performance score >=85%
15
Performance score >=80%
5
Performance score <80%
0
ASPIRE Tobacco Cessation Measure (SMOK-02)
Aggregation level: Hospital
For adult patients requiring anesthesia and identify as current smokers within
30 days prior to Anesthesia Start through Anesthesia End, have
documentation of tobacco/nicotine cessation intervention within 30 days
before surgery through Anesthesia End, including advising patients to quit,
providing counseling on cessation, and/or referral/resources for cessation
provided by the anesthesiology clinical care team at a rate of >=90% of
current smokers.
***referral alone does not qualify as an intervention***
>= 90% of current smokers received qualifying tobacco/nicotine cessation
intervention
20
>=85% and <90% of current smokers received qualifying tobacco/nicotine
cessation intervention
10
>=80% and <85% of current smokers received qualifying tobacco/nicotine
cessation intervention
5
<80% of current smokers received qualifying tobacco/nicotine cessation
intervention
0
Total Points Possible
100
120%
215%
620%
315%
415%
515%
For more information, visit ASPIRE 2028 VBR Program